Activist investor demands Keros 'aggressively' cut costs just weeks after layoffs
Keros Therapeutics’ pledge to hand $375 million to shareholders has not been enough to appease activist investor demands to slash further costs just weeks after the biotech laid off staff.
Keros Therapeutics’ pledge to hand $375 million to shareholders has not been enough to appease activist investor demands to slash further costs just weeks after the biotech laid off staff.
